ℹ️
🇬🇧
Search
Search for publications relevant for "il-33"
il-33
Publication
Class
Person
Publication
Programmes
publication
Alarmin interleukin-33 (IL-33) and its role in pathogenesis of atopic dermatitis
2023 |
Faculty of Medicine in Hradec Králové
publication
Alarmins - novel targets for biological therapy
2023 |
Faculty of Medicine in Hradec Králové
publication
Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris
2020 |
Faculty of Medicine in Hradec Králové
publication
Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis
2015 |
First Faculty of Medicine
publication
Interleukin-33, a Novel Member of the IL-1/IL-18 Cytokine Family, in Cardiology and Cardiac Surgery
2010 |
Faculty of Medicine in Hradec Králové
publication
The counter-regulation of atherogenesis: a role for interleukin-33
2010 |
Faculty of Medicine in Hradec Králové
publication
Actual position of interleukin(IL)-33 in atherosclerosis and heart failure: Great Expectations or En attendant Godot?
2015 |
Faculty of Medicine in Hradec Králové
publication
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
2023 |
Faculty of Medicine in Pilsen
publication
Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats
2023 |
First Faculty of Medicine
publication
Paradoxes and Pitfalls of Interleukin-33 in Atherosclerosis
2012 |
Faculty of Medicine in Hradec Králové
publication
Goeckerman Regimen Reduces Alarmin Levels and PASI Score in Paediatric Patients with Psoriasis
2021 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus
2015 |
First Faculty of Medicine
publication
The Impact of Selected Cytokines in the Follow-Up of Normal Pressure Hydrocephalus
2015 |
First Faculty of Medicine
publication
Identification and validation of biomarkers associated with acute and chronic graft versus host disease
2015 |
Third Faculty of Medicine
publication
OXIDATIVE STRESS MARKER ALLANTOIN IS NOT ASSOCIATED WITH THE CHANGE OF SERUM URIC ACID LEVEL IN PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES AFTER ABROGATION OF SYSTEMIC INFLAMMATION BY TNF INHIBITION
Publication without faculty affiliation
publication
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study
2022 |
First Faculty of Medicine, Faculty of Science, Second Faculty of Medicine
publication
Serum uric acid increases in patients with systemic autoimmune rheumatic diseases after 3 months of treatment with TNF inhibitors
2019 |
First Faculty of Medicine, Faculty of Science, Faculty of Mathematics and Physics
publication
Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
2021 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
2021 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine